MerckCo USA 거래 MRK

MerckCo 실시간 차트

상품 기초

Weekly Search
Weekly
Daily
날짜 종료 변경 변동(%) 열기 높음 낮음

MerckCo news

Big Tech, Apple, Meta, Microsoft, Amazon & Alphabet
Neil Wilson 2024 Oct 24, 16:00

Week ahead: Apple leads big tech earnings, UK Budget and Nonfarm Payrolls

Forex Indices
Bank of England, BoJ, Fed all hold policy meetings this week
Georgy Istigechev 2024 Jul 25, 16:00

Week ahead: Eurozone inflation, Fed meeting, Apple earnings

Forex Indices
Magnificent Seven earnings take centre stage in the markets this week
Neil Wilson 2024 Apr 19, 01:00

Week ahead: Wall Street’s Magnificent Seven earnings are up

Commodities Forex Indices Shares
The Bank of England
Neil Wilson 2024 Jan 25, 08:03

Week ahead: Fed, BoE to hold; Apple leads big tech earnings

Forex Indices
Moderna Share Price
Georgy Istigechev 2024 Jan 03, 08:01

Moderna share price jumps as Oppenheimer upgrades stock

Shares

최신 뉴스

더 보기
Noah Lee 2025 Aug 27, 09:20

Asian Markets Ease Gold ETF Restrictions Amid Geopolitical Uncertainty

Ava Grace 2025 Aug 27, 08:20

Russia's Economic Dilemma: Will the Ukraine War Push Towards Peace?

Ava Grace 2025 Aug 27, 07:20

Goldman Sachs Predicts Oil Prices to Plunge to $50s by 2026: Analyzing the Forecast

Noah Lee 2025 Aug 27, 06:20

Cryptocurrency in Venezuela: An Economic Lifeline Amidst Hyperinflation and Sanctions

Liam James 2025 Aug 27, 06:20

Cambricon Shares Surge Amidst AI Chip Demand

Emma Rose 2025 Aug 27, 05:20

US Tariffs on India: Economic Impact and Analysis

Liam James 2025 Aug 27, 03:20

Iran Nuclear Deal Talks Stall: UN Sanctions Revival Looms

Emma Rose 2025 Aug 27, 03:20

ExxonMobil Rethinks Sakhalin: A Potential Return Amid Geopolitical Shifts

정보

스프레드

0.53

스프레드(%)

0.6245 %

레버리지

1:10

익일 이자 매수

-0.0597 %

익일 이자 매도

-0.0292 %

통화

USD

거래 시간

시장 폐장

수요일

13:31 - 19:59

월요일

13:31-19:59

화요일

13:31-19:59

목요일

13:31-19:59

금요일

13:31-19:59

분석 및 통계

열기

---

이전 종가

---

52주 최고/최저

--- – ---

시가총액

213085601792

발행 주식 수

2497779968

수익 날짜 (다음)

2021-06-03

배당수익률

2025-10-07

배당락일

2025-09-15

예상 연간 배당금

3.24

예상 연간 배당수익률

0.0371

EPS

6.49

이 상품에 대해 자세히 알아보기

MerckCo USA Merck & Company Inc
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions for animal identification, monitoring and traceability; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. The company has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types, and Koselugo for multiple indications; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. It has a collaboration agreement with Antengene Corporation Limited to evaluate the combination of ATG-022, a CLDN18.2-targeting antibody-drug conjugate, and ant

latest_education_articles

더 보기
Trustpilot